2015•The Lancet NeurologyOpen access

Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study

Xuya Huang, Bharath Kumar Cheripelli, Suzanne M. Lloyd, Dheeraj Kalladka, Fiona Moreton, A Siddiqui, Ian Ford, Keith W. Muir

Open full text 337 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 337 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Tenecteplase, Medicine, Thrombolysis, Penumbra, Clinical endpoint, Stroke (engine), Fibrinolytic agent, Tissue plasminogen activator

Back to paper search Browse research topics Original source

Alteplase versus tenecteplase for thrombolysis after ischaemic stroke (ATTEST): a phase 2, randomised, open-label, blinded endpoint study — Research Paper | ScholarLens